CASE STUDY: Can Novartis India Reboot Star Brand Voveran?
This article was originally published in PharmAsia News
Executive Summary
Faced with savvy competitor introductions and government price cuts, Voveran, a star painkiller brand from Novartis, is seeing unprecedented market challenges in India. Can it survive the onslaught and what is the company doing to revive the product?